• Mashup Score: 0

    NICE has today (18 May 2023) issued final draft guidance which recommends dapagliflozin (also called Forxiga and made by AstraZeneca) as an option for adults with symptomatic chronic heart failure with preserved or mildly reduced ejection fraction. Heart failure with preserved or mildly reduced ejection fraction happens when the left side of the heart doesn’t fill properly with blood during the…

    Tweet Tweets with this article
    • 💥Great news @NICEComms https://t.co/3JuqKvKutx Huge win for people with #heartfailure & preserved/mildly reduced EF #HFpEF #HFmrEF @BSHeartFailure @BSHNurseForum @CarysBarton @PoppyBrooks1 @drpmcampbell @savodoc @DrRaniKhatib @foziaahmedMD @clarejtaylor @AhmetFU38380786 https://t.co/wo9kVS3jxn

  • Mashup Score: 16

    ShortURL is a URL shortener to reduce a long link. Use our tool to shorten links and then share them, in addition you can monitor traffic statistics.

    Tweet Tweets with this article
    • 🔥 #PICP associated with #myocardialfibrosis predicts #LV Reverse Remodeling & it is associated with outcomes in #HFrEF & #HFmrEF 👉Focus on the importance of a multiparametric evaluation in #HF @JACCJournals @BiykemB @JJheart_doc @gcfmd @DrMarthaGulati https://t.co/7G3blrEEnX https://t.co/GxCb9EvgC8